These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 12130550)

  • 1. Antigen presentation by vaginal cells: role of TGFbeta as a mediator of estradiol inhibition of antigen presentation.
    Wira CR; Roche MA; Rossoll RM
    Endocrinology; 2002 Aug; 143(8):2872-9. PubMed ID: 12130550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigen-presenting cells in the female reproductive tract: influence of estradiol on antigen presentation by vaginal cells.
    Wira CR; Rossoll RM; Kaushic C
    Endocrinology; 2000 Aug; 141(8):2877-85. PubMed ID: 10919275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigen-presenting cells in the female reproductive tract: influence of sex hormones on antigen presentation in the vagina.
    Wira CR; Rossoll RM
    Immunology; 1995 Apr; 84(4):505-8. PubMed ID: 7790022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oestradiol regulation of antigen presentation by uterine stromal cells: role of transforming growth factor-beta production by epithelial cells in mediating antigen-presenting cell function.
    Wira CR; Rossoll RM
    Immunology; 2003 Jul; 109(3):398-406. PubMed ID: 12807486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developmental and hormonal regulation of transforming growth factor-beta1 (TGFbeta1), -2, and -3 gene expression in isolated prostatic epithelial and stromal cells: epidermal growth factor and TGFbeta interactions.
    Itoh N; Patel U; Cupp AS; Skinner MK
    Endocrinology; 1998 Mar; 139(3):1378-88. PubMed ID: 9492075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of oestradiol and pathogen-associated molecular patterns on class II-mediated antigen presentation and immunomodulatory molecule expression in the mouse female reproductive tract.
    Ochiel DO; Rossoll RM; Schaefer TM; Wira CR
    Immunology; 2012 Jan; 135(1):51-62. PubMed ID: 22043860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preferential production of latent transforming growth factor beta-2 by primary prostatic epithelial cells and its activation by prostate-specific antigen.
    Dallas SL; Zhao S; Cramer SD; Chen Z; Peehl DM; Bonewald LF
    J Cell Physiol; 2005 Feb; 202(2):361-70. PubMed ID: 15389580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigen-presenting cells in the female reproductive tract: influence of the estrous cycle on antigen presentation by uterine epithelial and stromal cells.
    Wira CR; Rossoll RM
    Endocrinology; 1995 Oct; 136(10):4526-34. PubMed ID: 7664673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of in vivo regulatory properties of T cells activated in vitro by TGFbeta2-treated antigen presenting cells.
    Kezuka T; Streilein JW
    Invest Ophthalmol Vis Sci; 2000 May; 41(6):1410-21. PubMed ID: 10798657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of treatment with antibodies to transforming growth factor beta1 and beta2 following spinal cord damage in the adult rat.
    King VR; Phillips JB; Brown RA; Priestley JV
    Neuroscience; 2004; 126(1):173-83. PubMed ID: 15145083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of transforming growth factor-β subtypes on in vitro cartilage production and mineralization of human bone marrow stromal-derived mesenchymal stem cells.
    Cals FL; Hellingman CA; Koevoet W; Baatenburg de Jong RJ; van Osch GJ
    J Tissue Eng Regen Med; 2012 Jan; 6(1):68-76. PubMed ID: 21305699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TCR transgenic CD8+ T cells activated in the presence of TGFbeta express FoxP3 and mediate linked suppression of primary immune responses and cardiac allograft rejection.
    Kapp JA; Honjo K; Kapp LM; Xu Xy; Cozier A; Bucy RP
    Int Immunol; 2006 Nov; 18(11):1549-62. PubMed ID: 16966495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of transforming growth factor-beta2 facilitates inflammation in the central nervous system by reciprocal astrocyte/microglia interactions.
    Siglienti I; Chan A; Kleinschnitz C; Jander S; Toyka KV; Gold R; Stoll G
    J Neuropathol Exp Neurol; 2007 Jan; 66(1):47-56. PubMed ID: 17204936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opposing actions of two transforming growth factor-beta isoforms on pituitary lactotropic cell proliferation.
    Hentges S; Pastorcic M; De A; Boyadjieva N; Sarkar DK
    Endocrinology; 2000 Apr; 141(4):1528-35. PubMed ID: 10746660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of transforming growth factor beta production by nitric oxide-treated chondrocytes: implications for matrix synthesis.
    Studer RK; Georgescu HI; Miller LA; Evans CH
    Arthritis Rheum; 1999 Feb; 42(2):248-57. PubMed ID: 10025918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific IgA and IgG antibodies in the secretions of the female reproductive tract: effects of immunization and estradiol on expression of this response in vivo.
    Wira CR; Sandoe CP
    J Immunol; 1987 Jun; 138(12):4159-64. PubMed ID: 3584972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normal human keratinocytes inhibit the proliferation of unprimed T cells by TGFbeta and PGE2, but not IL-10.
    Laning JC; Isaacs CM; Hardin-Young J
    Cell Immunol; 1997 Jan; 175(1):16-24. PubMed ID: 9015184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex hormone and IL-6 regulation of antigen presentation in the female reproductive tract mucosal tissues.
    Prabhala RH; Wira CR
    J Immunol; 1995 Dec; 155(12):5566-73. PubMed ID: 7499839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombospondin orchestrates the tolerance-promoting properties of TGFbeta-treated antigen-presenting cells.
    Masli S; Turpie B; Streilein JW
    Int Immunol; 2006 May; 18(5):689-99. PubMed ID: 16569680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estradiol-induced vaginal mucus inhibits antigen penetration and CD8(+) T cell priming in response to intravaginal immunization.
    Seavey MM; Mosmann TR
    Vaccine; 2009 Apr; 27(17):2342-9. PubMed ID: 19428849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.